AtriCure, Inc.
ATRC
$37.90
$0.2350.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 10.13% | -0.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.13% | -0.53% | |||
| Cost of Revenue | 11.83% | -2.10% | |||
| Gross Profit | 9.56% | 0.01% | |||
| SG&A Expenses | 3.07% | 5.36% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.85% | -6.65% | |||
| Operating Income | -4.00% | 59.00% | |||
| Income Before Tax | 8.90% | 57.47% | |||
| Income Tax Expenses | 9.21% | -10.15% | |||
| Earnings from Continuing Operations | 8.26% | 56.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.26% | 56.66% | |||
| EBIT | -4.00% | 59.00% | |||
| EBITDA | -17.36% | 91.03% | |||
| EPS Basic | 8.92% | 56.90% | |||
| Normalized Basic EPS | 9.44% | 57.71% | |||
| EPS Diluted | 8.92% | 56.90% | |||
| Normalized Diluted EPS | 9.44% | 57.71% | |||
| Average Basic Shares Outstanding | 0.69% | 0.57% | |||
| Average Diluted Shares Outstanding | 0.69% | 0.57% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||